Unlock Human-Relevant Insights Early
Our stem cell services provide human-relevant, mechanistic data to guide early-stage research and lead optimization.
These multi-scale formats allow translation from cellular to tissue-level function.
Our stem cell studies are supported by industry-standard platforms for electrophysiology, imaging, and 3D tissue modeling.
SyncroPatch 384 / Patchliner (Nanion)
Automated patch clamp for iPSC-derived cells.
The SyncroPatch 384 and Patchliner enable high-quality electrophysiological recordings from fragile iPSC-derived cardiomyocytes and neurons, supporting both high-throughput screening and detailed characterization of ion channel activity.
Best suited for: Ion channel pharmacology, action potential profiling, drug safety screening
NANION TECHNOLOGIES HIGH THROUGHPUT
MEA Systems (Multi Channel Systems)
Network-level electrophysiology.
Microelectrode Array (MEA) technology records extracellular field potentials from iPSC-derived cardiomyocyte or neuronal networks, capturing spontaneous activity, drug-induced changes in beat rate, and arrhythmia-like events in a physiological context.
Best suited for: Network activity analysis, cardiotoxicity / neurotoxicity assessment, chronic drug exposure
MCS PHYSIOLOGICAL RELEVANCE
High-Speed sCMOS Imaging (Kinetix)
High-speed functional imaging.
The Kinetix sCMOS camera enables rapid imaging of calcium transients and voltage dynamics in large cell populations with exceptional temporal resolution, supporting phenotypic analysis across 2D monolayers and 3D tissues.
Best suited for: Calcium handling, voltage dynamics, high-content phenotypic profiling
PHOTOMETRICS HIGH SPEED
3D Microtissue Platforms
Tissue-level modeling.
3D spheroid and organoid platforms allow iPSC-derived cells to self-organize into architecturally relevant microtissues, enabling studies that better recapitulate in vivo physiology compared to standard 2D cultures.
Best suited for: Disease modeling, toxicity studies in complex tissue environments, translational research
3D MODELS ORGANOIDS
Define biological questions and experimental endpoints.
Optimize cell type and format for mechanistic insight.
Rigorous experimental execution with reproducible results.
Deliver actionable, decision-ready insights.
Common questions about ChanPharm's stem cell studies, iPSC cardiomyocyte and neuron assays, and 3D microtissue models.
Why use iPSC-derived models for drug discovery?
Human iPSC-derived cardiomyocytes and neurons recapitulate human-specific ion channel expression and electrophysiology far better than rodent or recombinant models. This reduces late-stage translation failure for cardiac and CNS programmes — a documented contributor to clinical attrition.
What readouts do you offer on iPSC cardiomyocytes?
Patch clamp ionic currents (Nav1.5, hERG, Cav1.2, IK1, etc.), MEA field-potential and beat-rate analysis, contractility, calcium transients via Kinetix sCMOS imaging, and CiPA-aligned proarrhythmia panels — see our cardiac safety page for details.
Which iPSC neuronal models can you screen?
Human iPSC-derived cortical excitatory neurons, GABAergic interneurons, sensory neurons (DRG-like for pain programmes), and motor neurons on request. We work with commercial lines (iCell, Axol, BrainXell) and accept client-supplied lines. See our neurotoxicity services page for workflows.
Do you support 3D microtissue / organoid studies?
Yes. We run spheroid and organoid formats alongside 2D cultures when tissue-level interactions or extended maturation are critical for the question. 3D models better recapitulate in vivo electrophysiology for both cardiac and CNS contexts.
What instruments support iPSC electrophysiology at ChanPharm?
The Nanion SyncroPatch 384 and Patchliner for automated patch clamp, manual patch clamp for detailed kinetics, MEA for network-level assays, and Kinetix sCMOS imaging for high-speed calcium/voltage indicators.
How does iPSC screening fit into a typical drug discovery workflow?
For cardiac programmes: hERG/multi-channel panel → iPSC-cardiomyocyte MEA → CiPA in silico (see cardiac safety). For CNS programmes: target-specific patch clamp → iPSC neuronal MEA for network-level effects (see neurotoxicity). We tailor workflow design to each programme.